Table 4.
Authors | Follow-up (months) | Total number of recurrences |
---|---|---|
Badalamene et al. 12 | 20 | 3/35 (8.5%) |
Badalamene et al. 28 | 24 | 5/35 (14%) |
Hurst et al. 29 | 3 | 0/306 (0%) |
Watt et al. 15 | 88 | 6/8 (75%) |
Gilpin et al. 30 | 12 | 0/66 (0%) |
Witthaut et al. 38 | 9 | 19/497 (4%) |
Peimer et al. 39 | 36 | 217/623 (35%) |
Nydick et al. 36 | 6 | 0/59 (0%) |
Naam41 | 24 | 0/61 (0%) |
Mc Mahon et al. 42 | 15 | 13/48 (28%) |
Alberton et al. 45 | 6 | 2/40 (3.8%) |
Peimer et al. 53 | 60 | 291/623 (47%) |